Skip to search formSkip to main contentSkip to account menu

Eletriptan Hydrobromide

Known as: (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide, 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide, 3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole, Monohydrobromide 
A triptan with specific affinity for the 5-hydroxytriptamine1B/1D receptor. Eletriptan hydrobromide binds to and acts at serotonin 5-HT1B receptors… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The objective of the current study was to formulate and characterize thermoreversible gel of Eletriptan Hydrobromide for brain… 
Review
2013
Review
2013
OBJECTIVES To conduct a systematic review and analysis of trial data submitted to the US Food and Drug Administration (FDA) to… 
2012
2012
Eletriptan hydrobromide (1) is a selective serotonin (5-HT1) agonist, used for the acute treatment of the headache phase of… 
2012
2012
Simple, accurate, precise, linear and reproducible method was developed for the estimation of Eletriptan hydrobromide… 
2010
2010
Objective.— To prospectively evaluate the efficacy of perimenstrual prophylaxis with eletriptan to reduce headaches in women… 
2010
2010
A reverse phase high performance liquid chromatographic method has been described for the estimation of eletriptan in its… 
2006
2006
Objective.—The objective of this open‐label study was to evaluate the efficacy of switching patients who had a previous… 
2006
2006
Arapid and sensitive RPHPLCmethod was developed for the routine control analysis of eletriptan hydrobromide and its organic… 
1998
1998
The anti-cancer compound CI-1010, designated as (R)-α-([(2-bromoethyl)amino]methyl)-2-nitro-]H-imidazole-l-ethanol…